MRI shows drugs that can prevent heart damage in breast cancer patients

Researchers who led a new landmark clinical trail using carding MRI found that combining heart medication with chemotherapy reduces the risk of heart damage in patients with early-stage breast cancer.

The new five year study at the University of Alberta and Alberta Health Services found that beta blockers and ACE inhibitors, effectively prevent a drop in heart function from cancer treatment.  

The study is funded by the Canadian Institutes of Health Research (CIHR) and Alberta Cancer Foundation.  

Read the full article here: